Browse News
Filter News
Found 664,214 articles
-
The U.S. FDA expanded the Emergency Use Authorization for the Pfizer and BioNTech vaccine to include adolescents ages 12 to 15 after clinical data showed 100% efficacy response.
-
Eli Lilly announced a drug development collaboration with MiNA Therapeutics Limited focusing on five novel drug candidates that could be worth up to $245 million.
-
Appia is developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients.
-
The 24th Annual meeting of the American Society of Gene & Cell Therapy presents cutting-edge work in the booming area of gene and cell therapy. Here’s a look at a few of the highlights.
-
2021 is shaping up to be another banner year for biotech companies as they advance the next gen technologies and therapeutics for the health of all. Here’s a few raking in cash for their programs today.
-
Cystic Fibrosis: One Patient’s Story, Current Treatments and Exciting New Therapies on the Horizon
5/11/2021
“The recent progress of cystic fibrosis drugs has been amazing and, in my case, miraculous,” said Kelly Peters, who lives with cystic fibrosis. “The new drugs are not a cure, but they feel pretty close.” -
Biogen and Capsigen forged a strategic collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to become transformative gene therapies that treat underlying genetic causes of various central nervous system and neuromuscular disorders.
-
Biotechnology firm Ginkgo Bioworks is going public via a merger with Soaring Eagle Acquisition Corp.
-
Clearance of the IND allows Samus to proceed with a Phase Ib trial to assess the safety, tolerability and pharmacokinetics of PU-AD in a small group of patients with recurrent malignant glioma.
-
Top 12 Biotech Companies Hiring Now
5/11/2021
Despite the COVID-19 pandemic taking a hit on other industries, the biotech industry continues to grow and so do salaries. Biotech companies keep adding jobs and the market is hot! Check out these hot companies who are looking for candidates like you right now! -
2021 COVID-19 News: India Variant a Global Concern, Low Risk of Serious Long Term Effects and More
5/11/2021
Please check out the biopharma industry's COVID-19 stories that are trending for May 11, 2021. -
AbbVie's Allergan Aesthetics' most well-known brands right now include BOTOX and CoolSculpting, among others. However, with the company's latest acquisition, another one might slide its way to the top.
-
Cyclo Therapeutics Appoints Lori McKenna Gorski as Global Head of Patient Advocacy
5/11/2021
Ms. Gorski brings more than two decades of communications and patient advocacy experience serving rare disease communities Formerly led global communications and patient advocacy strategies for lysosomal storage disorders at Sanofi Genzyme
-
DermaSensor Granted FDA Breakthrough Device Designation
5/11/2021
FDA designation fast tracks getting cancer detection device in the hands of healthcare professionals
-
SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI and Adds Respiratory Advisory Team
5/11/2021
- Grant award to fund formulation of inhaled therapy for chronic cough - - Cough advisory team includes 4 acclaimed researchers -
-
AIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate Update
5/11/2021
Key Milestone Approaching with Testing Data Publication and Technology Advancement Results Expected this Quarter Cash Balance of $102 million or approximately $1.15 per share as of March 31st Positioned for Strategic Initiatives and Technology Development
-
Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes
5/11/2021
Using a proactive prescriber outreach program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, saw increased statin use in Medicare members with diabetes
-
AUM Biosciences enters in a Strategic Collaboration with Handok and CMG Pharm to develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment
5/11/2021
AUM Biosciences enters in a Strategic Collaboration with Handok and CMG Pharm to develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment AUM will receive worldwide rights excluding Korea in all indications
-
Molecular Targeting Technologies, Inc. and University of Antwerp Begin First-in-Human Study of TDURA Diagnostic for Early Detection of Response to Colon Cancer Therapy
5/11/2021
Molecular Targeting Technologies, Inc. (MTTI) and University of Antwerp today announced the approval of a Clinical Trial Application by the European Federal Agency for Medicines and Health Products (FAMHP) (equivalent to a US IND). The clinical study will evaluate the safety, dosimetry and treatment response of TDURA ( 99m Tc-Duramycin), in patients with advanced colorectal cancer (CRC)*.
-
Navigo Proteins and MDimune Enter into a Research Collaboration on Affilin®-Mediated Targeting of Extracellular Vesicles
5/11/2021
Solid tumor-specific scaffold protein ligands from Navigo combined with MDimune’s BioDrone® technology to create novel targeted extracellular vesicle-based therapeutics